As of 2026-09-12, the Relative Valuation of FibroGen Inc (FGEN) is 1,432.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.71 USD, the upside of FibroGen Inc based on Relative Valuation is 14651.5%.
The range of the Relative Valuation is 1,246.00 - 1,618.74 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 23.4x - 30.4x | 26.9x |
| Fair Price | 1,246.00 - 1,618.74 | 1,432.37 |
| Upside | 12732.1% - 16570.8% | 14651.5% |
| Date | P/E |